Structure-dependent inhibition of bladder and pancreatic cancer cell growth by 2-substituted glycyrrhetinic and ursolic acid derivatives

scientific article published on 14 March 2008

Structure-dependent inhibition of bladder and pancreatic cancer cell growth by 2-substituted glycyrrhetinic and ursolic acid derivatives is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.BMCL.2008.03.031
P932PMC publication ID2408873
P698PubMed publication ID18359628
P5875ResearchGate publication ID5492019

P2093author name stringStephen Safe
Alan McAlees
Gayathri Chadalapaka
Indira Jutooru
Tom Stefanac
P2860cites workA history of the therapeutic use of liquorice in EuropeQ36174968
2-cyano-lup-1-en-3-oxo-20-oic acid, a cyano derivative of betulinic acid, activates peroxisome proliferator-activated receptor gamma in colon and pancreatic cancer cellsQ40088710
Structure-dependent activity of glycyrrhetinic acid derivatives as peroxisome proliferator-activated receptor {gamma} agonists in colon cancer cellsQ40130462
Synthetic oleanane and ursane triterpenoids with modified rings A and C: a series of highly active inhibitors of nitric oxide production in mouse macrophagesQ43509294
Design and synthesis of 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid, a novel and highly active inhibitor of nitric oxide production in mouse macrophagesQ77749464
Pharmacology of oleanolic acid and ursolic acidQ28292594
Novel synthetic oleanane and ursane triterpenoids with various enone functionalities in ring A as inhibitors of nitric oxide production in mouse macrophagesQ28378280
A synthetic triterpenoid, 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO), is a ligand for the peroxisome proliferator-activated receptor gammaQ31483885
Betulinic acid and its derivatives: a review on their biological propertiesQ36079811
P433issue8
P407language of work or nameEnglishQ1860
P921main subjectcell growthQ189159
pancreatic cancerQ212961
P304page(s)2633-2639
P577publication date2008-03-14
P1433published inBioorganic & Medicinal Chemistry LettersQ2709483
P1476titleStructure-dependent inhibition of bladder and pancreatic cancer cell growth by 2-substituted glycyrrhetinic and ursolic acid derivatives
P478volume18

Reverse relations

cites work (P2860)
Q35923150Age-associated chronic diseases require age-old medicine: role of chronic inflammation
Q39346069An Overview of Structurally Modified Glycyrrhetinic Acid Derivatives as Antitumor Agents
Q38713053Bardoxolone Methyl and a Related Triterpenoid Downregulate cMyc Expression in Leukemia Cells.
Q37854752Clinically useful anticancer, antitumor, and antiwrinkle agent, ursolic acid and related derivatives as medicinally important natural product
Q38125067Cytotoxic activity of ursolic acid derivatives obtained by isolation and oxidative derivatization.
Q35108020Evolution in medicinal chemistry of ursolic acid derivatives as anticancer agents
Q38892406Glycyrrhetinic acid potently suppresses breast cancer invasion and metastasis by impairing the p38 MAPK-AP1 signaling axis
Q55076389HDAC and Ku70 axis- an effective target for apoptosis induction by a new 2-cyano-3-oxo-1,9-dien glycyrrhetinic acid analogue.
Q30318376Improvement of the cytotoxicity and tumor selectivity of glycyrrhetinic acid by derivatization with bifunctional amino acids.
Q37351464Induction of apoptosis and nonsteroidal anti-inflammatory drug-activated gene 1 in pancreatic cancer cells by a glycyrrhetinic acid derivative
Q42237311Induction of apoptosis with mitochondrial membrane depolarization by a glycyrrhetinic acid derivative in human leukemia K562 cells
Q36783835Induction of the transcriptional repressor ZBTB4 in prostate cancer cells by drug-induced targeting of microRNA-17-92/106b-25 clusters
Q35083801Inhibition of pituitary tumor-transforming gene-1 in thyroid cancer cells by drugs that decrease specificity proteins
Q34051649Methyl 2-cyano-3,12-dioxooleana-1,9-dien-28-oate decreases specificity protein transcription factors and inhibits pancreatic tumor growth: role of microRNA-27a
Q41820952Oleanolic acid derivatives induce apoptosis in human leukemia K562 cell involved in inhibition of both Akt1 translocation and pAkt1 expression
Q37397551Oncogenic microRNA-27a is a target for anticancer agent methyl 2-cyano-3,11-dioxo-18beta-olean-1,12-dien-30-oate in colon cancer cells
Q37173329Plant-derived triterpenoids and analogues as antitumor and anti-HIV agents
Q39312759Semisynthetic ursolic acid fluorolactone derivatives inhibit growth with induction of p21(waf1) and induce apoptosis with upregulation of NOXA and downregulation of c-FLIP in cancer cells
Q27309197Synergism of ursolic acid derivative US597 with 2-deoxy-D-glucose to preferentially induce tumor cell death by dual-targeting of apoptosis and glycolysis
Q39590536Synthesis and pro-apoptotic activity of novel glycyrrhetinic acid derivatives.
Q42958718The synthesis of glycyrrhetinic acid derivatives containing a nitrogen heterocycle and their antiproliferative effects in human leukemia cells.
Q36494764Unifying mechanisms of action of the anticancer activities of triterpenoids and synthetic analogs
Q39614477Ursolic acid induces apoptosis by suppressing the expression of FoxM1 in MCF-7 human breast cancer cells
Q36916312Ursolic acid inhibits growth and metastasis of human colorectal cancer in an orthotopic nude mouse model by targeting multiple cell signaling pathways: chemosensitization with capecitabine
Q37022420Ursolic acid inhibits the growth of human pancreatic cancer and enhances the antitumor potential of gemcitabine in an orthotopic mouse model through suppression of the inflammatory microenvironment
Q34125151Use of dietary phytochemicals to target inflammation, fibrosis, proliferation, and angiogenesis in uterine tissues: promising options for prevention and treatment of uterine fibroids?

Search more.